The hurdle of drug resistance could be innate, acquired, or cross-resistance/MDR with different underlying mechanisms such as drug sequestration by P-gp, proliferation potential of mutated cancer stem cells (CSCs), altering drug target, modification of DNA repair strategies, altering drug detoxification, and invalid apoptotic regulators such as p53 [28,29]. This evidence concerns the gene TP53 and cancer.